You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dasabuvir

Showing 1 - 25 of 88
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis C Infection, Hepatitis C Virus Trial (ombitasvir/paritaprevir/ritonavir, dasabuvir)

Completed
Has Results
  • Hepatitis C Infection
  • Hepatitis C Virus
  • (no location specified)
Jul 28, 2021

Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • Compensated Cirrhosis
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Infection
  • Compensated Cirrhosis
  • ABT-450/r/ABT-267, ABT-333
  • Ribavirin (RBV)
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C Infection Trial in Worldwide (Ombitasvir/paritaprevir/ritonavir, Dasabuvir, Ribavirin)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • San Francisco, California
  • +20 more
Sep 7, 2021

Hepatitis C, Acute Trial in Australia, New Zealand, United Kingdom (Paritaprevir/ritonavir/ombitasvir, Dasabuvir, Ribavirin)

Recruiting
  • Hepatitis C, Acute
  • Sydney, New South Wales, Australia
  • +10 more
Jun 23, 2021

Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-450/r/ABT-267, ABT-333,

Completed
Has Results
  • Hepatitis C Virus Infection
  • +3 more
  • (no location specified)
Jul 8, 2021

Hepatitis C, Chronic Trial in United States (ombitasvir, paritaprevir/r, dasabuvir + ribavirin, ombitasvir, paritaprevir/r,

Completed
Has Results
  • Hepatitis C, Chronic
  • ombitasvir, paritaprevir/r, dasabuvir + ribavirin
  • ombitasvir, paritaprevir/r, dasabuvir
  • Irvine, California
  • +3 more
Jan 21, 2021

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +4 more
  • (no location specified)
Jul 29, 2021

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +4 more
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for Ribavirin)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +2 more
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ribavirin)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +2 more
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C Infection, HBV Coinfection, Hepatitis B Reactivation Trial in Hong Kong (Ledipasvir/Sofosbuvir, Sofosbuvir

Completed
  • Chronic Hepatitis C Infection
  • +2 more
  • Hong Kong, Hong Kong, China
    Humanity and Health GI and Liver Centre
Aug 27, 2021

Against HCV Based on Direct-acting Antivirals in Real-life

Completed
  • Chronic Hepatitis C Infection
  • Seville, Andalusia, Spain
    Valme University Hospital
Jun 22, 2022

Chronic Hepatitis C, Hepatitis C Virus, Compensated Cirrhosis Trial (ABT-493, ABT-530, ABT-450/r/ABT-267, ABT-333)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 8, 2021

Hepatitis C Virus (HCV) Trial (ombitasvir/paritaprevir/ritonavir and dasabuvir, ribavirin)

Completed
Has Results
  • Hepatitis C Virus (HCV)
  • ombitasvir/paritaprevir/ritonavir and dasabuvir
  • ribavirin
  • (no location specified)
Nov 27, 2019

HIV, Hepatitis C Trial in Puerto Rico, United States (Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT), Dasabuvir (DSV), Ribavirin

Terminated
Has Results
  • HIV Infections
  • Hepatitis C
  • Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT)
  • +2 more
  • Birmingham, Alabama
  • +15 more
Nov 2, 2021

Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

Completed
Has Results
  • Chronic Hepatitis C
    • (no location specified)
    Sep 16, 2019

    Naïve Hepatitis C Virus Genotype 1 Suffering From Fatigue and

    Completed
    Has Results
    • Chronic Hepatitis C Virus (HCV)
      • St. Gallen, Sankt Gallen, Switzerland
      • +4 more
      Sep 30, 2019

      Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

      Completed
      Has Results
      • Chronic Hepatitis C
        • (no location specified)
        May 23, 2019

        Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

        Completed
        Has Results
        • Chronic Hepatitis C
          • Bogotá, Colombia
          • +5 more
          Aug 12, 2019

          Hepatitis C Trial in Ottawa (ABT450r-ABT267-ABT333 +/- Ribavirin)

          Completed
          • Hepatitis C
          • ABT450r-ABT267-ABT333 +/- Ribavirin
          • Ottawa, Ontario, Canada
            The Ottawa Hospital, General Campus
          Aug 9, 2019

          Chronic Hepatitis C Trial in United States (SOF/LDV (sofosbuvir/ledipasvir), PrOD (ombitasvir/paritaprevir/ritonavir with

          Completed
          Has Results
          • Chronic Hepatitis C
          • SOF/LDV (sofosbuvir/ledipasvir)
          • +3 more
          • Little Rock, Arkansas
          • +37 more
          Dec 1, 2021

          Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

          Completed
          Has Results
          • Chronic Hepatitis C
            • (no location specified)
            Feb 28, 2019

            Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and

            Completed
            Has Results
            • Chronic Hepatitis C
            • Be'er Sheva, HaDarom, Israel
            • +17 more
            Sep 18, 2019